|
Report No. : |
304762 |
|
Report Date : |
24.01.2015 |
IDENTIFICATION DETAILS
|
Name : |
BIOLOGICAL INDUSTRIES ISRAEL BEIT HA'EMEK LTD. |
|
|
|
|
Registered Office : |
Beit Ha'emek 2511500 |
|
|
|
|
Country : |
Israel |
|
|
|
|
Date of Incorporation : |
31.10.1990 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturers, traders, importers, exporters, marketers and
suppliers of life science products to universities, government research and
healthcare institutions and to the biopharmaceutical industry |
|
|
|
|
No. of Employees : |
90 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
Israel |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
ISRAEL - ECONOMIC
OVERVIEW
Israel has a technologically
advanced market economy. Cut diamonds, high-technology equipment, and
pharmaceuticals are among the leading exports. Its major imports include crude
oil, grains, raw materials, and military equipment. Israel usually posts
sizable trade deficits, which are covered by tourism and other service exports,
as well as significant foreign investment inflows. Between 2004 and 2011,
growth averaged nearly 5% per year, led by exports. The global financial crisis
of 2008-09 spurred a brief recession in Israel, but the country entered the
crisis with solid fundamentals, following years of prudent fiscal policy and a
resilient banking sector. In 2010, Israel formally acceded to the OECD.
Israel's economy also has weathered the Arab Spring because strong trade ties
outside the Middle East have insulated the economy from spillover effects. The
economy has recovered better than most advanced, comparably sized economies,
but slowing demand domestically and internationally, and a strong shekel, have
reduced forecasts for the next decade to the 3% level. Natural gas fields
discovered off Israel's coast since 2009 have brightened Israel's energy
security outlook. The Tamar and Leviathan fields were some of the world's
largest offshore natural gas finds this past decade. The massive Leviathan
field is not due to come online until 2018, but production from Tamar provided
a one percentage point boost to Israel's GDP in 2013 and is expected to
contribute 0.5% growth in 2014. In mid-2011, public protests arose around
income inequality and rising housing and commodity prices. Israel's income
inequality and poverty rates are among the highest of OECD countries and there
is a broad perception among the public that a small number of "tycoons"
have a cartel-like grip over the major parts of the economy. The government
formed committees to address some of the grievances but has maintained that it
will not engage in deficit spending to satisfy populist demands. In May 2013
the Israeli government, in a politically difficult process, passed an austerity
budget to reign in the deficit and restore confidence in the government's
fiscal position. Over the long term, Israel faces structural issues, including
low labor participation rates for its fastest growing social segments - the
ultra-orthodox and Arab-Israeli communities. Also, Israel's progressive,
globally competitive, knowledge-based technology sector employs only 9% of the
workforce, with the rest employed in manufacturing and services - sectors which
face downward wage pressures from global competition
|
Source
: CIA |
Correct Name: BIOLOGICAL INDUSTRIES ISRAEL BEIT HA'EMEK
LTD. (CORRECT NAME)
Telephone 972 4 996 05 95; 996 06 89
Fax 972 4 996 88 96
Email: info@bioind.com
BEIT HA'EMEK 2511500 ISRAEL
A private limited company, incorporated as per file No. 51-151314-5 on the 31.10.1990.
Subject was established in view of assuming part the business activities of a limited partnership BIOLOGICAL INDUSTRIES BEIT HA'EMEK, established by Kibbutz Beit Ha'emek on the 23.11.1976 (other activities, for plant propagation, moved to a sister company).
Originally registered under the name BIOLOGICAL INDUSTRIES COMPANY BEIT HA'EMEK (1990) LTD., which changed to the present name on the 01.07.2001.
Authorized share capital NIS 50,013,000,000.00, divided into -
50,013,000 ordinary shares of NIS 1.00 each,
of which 1,778,635 shares amounting to NIS 1,778,635.00 were issued.
Company is fully owned by BEIT HA'EMEK ECONOMIC DEVELOPMENT COMPANY 2000 LTD., OWNED BY Kibbutz Beit Haemek, a cooperative society, operating an agricultural communal settlement.
1. Shai Maretzki,
2. Garry Ben-Et,
3. Alon Hagai,
4. Yehoshua (Shuki) Bashan,
5. Peretz Livne,
6. Dov Lapid,
7. Dr. Stanley Hirsch,
8. Ms. Shoshana Arbel,
9. Yossef Eldor,
10. Ms. Daniela Yogev.
Alon Ariel
Manufacturers, traders, importers, exporters, marketers and suppliers of life science products to universities, government research and healthcare institutions and to the biopharmaceutical industry. The company's diverse portfolio of products and services includes all of the following: Liquid and powdered cell culture medium, Sterile serum (serum which subject imports and sterilizes), including Foetal Bovine Serum, Newborn, Donor horse, etc., Novel serum-free and animal component-free media and supplements, Products for stem cell culture, etc.
In 2014, 42% of sales are for export (37% in 2013, 33% in 2012), to 40 countries worldwide.
Operating from premises (plant, offices, storage facilities), owned by the shareholders, on an area of 7,000 sq. meters, in Kibbutz Beit Ha'emek, a locality in the North of Israel.
Note:
"Kibbutz" is a typical local cooperative agricultural settlement/
village.
Having 90 employees.
Subject is an “Approved Enterprise” and as such enjoys tax benefits and state incentives.
In June 2004, the Israeli Investment Center approved a US$ 1.6 million investment plant for the expansion of subject’s plant.
Other financial data not forthcoming.
There are 6 charges for an unlimited amounts, as well as 3 charges for total amount of NIS 1,341,000 registered on the company's assets (financial, fixed and other assets), in favor of the State of Israel, Bank Hapoalim Ltd. and in favor of another entity. Last 3 of charges placed in one in 2012 and 2 in 2014 (before that in 2009) on machinery and vehicles.
Sales figures not forthcoming.
Also owned by Kibbutz Beit Ha'emek:
BIOLOGICAL INDUSTRIES PLANT PROPAGATION LTD., engaged in the ornamental plant propagation industry.
BIOLOGICAL INDUSTRIES BEIT HA'EMEK, non-active.
Bank Hapoalim Ltd., Nahariya Business Branch (No. 168), Nahariya.
Nothing unfavorable learned.
This is a veteran business.
Subject is ISO 9001:2008 and ISO 13485:2003 certified.
Kibbutz Beit Ha'emek was established in 1949. There are some 220 members.
Besides subject and sister BIOLOGICAL INDUSTRIES PLANT PROPAGATION, they cultivate a large agricultural land, specializing in field crops, avocado, lychee and banana orchards. The kibbutz also operates several other smaller ventures (silk plant, special footwear), as well as recreation facilities.
Good for trade engagements.
Note: Regarding the address you provided, subject's General Manager told us she is not familiar with that address (correct one is as in caption), and it may be the address of subject's customs agents (as the address being in the Ben Gurion Airport, Maman House, it makes sense).
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.50 |
|
|
1 |
Rs.92.16 |
|
Euro |
1 |
Rs.69.62 |
INFORMATION DETAILS
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.